Exact Mass: 286.1794

Exact Mass Matches: 286.1794

Found 50 metabolites which its exact mass value is equals to given mass value 286.1794, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-Acetyl-leucyl-leucine

N-Acetyl-leucyl-leucine

C14H26N2O4 (286.1892)


   

Thonzylamine

N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyrimidin-2-amine

C16H22N4O (286.1794)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Thonzylamine is a first-generation ethylenediamine H1-antihistamine. Thonzylamine is an orally active H1 histamine receptor antagonist, exhibits good antihistaminic and antianaphylactic properties. Thonzylamine can be used for the research of hypersensitivity diseases, nasal congestion, allergic conjunctivitis and other allergic diseases[1][2].

   

Malkanguniol

Malkanguniol

C15H26O5 (286.178)


   

1,10:4,5-Diepoxy-6,11-germacranediol-(1R,4R,5R,6R,10R)-form-14-Hydroyx

1,10:4,5-Diepoxy-6,11-germacranediol-(1R,4R,5R,6R,10R)-form-14-Hydroyx

C15H26O5 (286.178)


   

cytospolide M

cytospolide M

C15H26O5 (286.178)


   

cytospolide Q

cytospolide Q

C15H26O5 (286.178)


   

cytospolide F

cytospolide F

C15H26O5 (286.178)


   

(2alpha,4beta,6alpha,8alpha,9alpha,10alpha)-8,9-Epoxy-2,4,6,10-daucanetetrol

(2alpha,4beta,6alpha,8alpha,9alpha,10alpha)-8,9-Epoxy-2,4,6,10-daucanetetrol

C15H26O5 (286.178)


   

2-dec-9-enyl-3-hydroxypentanedioic acid

NCGC00380897-01!2-dec-9-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

2-dec-4-enyl-3-hydroxypentanedioic acid

NCGC00381422-01!2-dec-4-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

tert-butyl 4-amino-4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate

tert-butyl 4-amino-4-(2-ethoxy-2-oxoethyl)piperidine-1-carboxylate

C14H26N2O4 (286.1892)


   

2-(1-PROPYL-4-PIPERIDINYL)-1H-BENZIMIDAZOLE-7-CARBOXAMIDE

1H-Benzimidazole-7-carboxamide, 2-(1-propyl-4-piperidinyl)-

C16H22N4O (286.1794)


   

hydroxy-2-oxoethyl]butyl]-,1,1-dimethylethyl ester

hydroxy-2-oxoethyl]butyl]-,1,1-dimethylethyl ester

C14H26N2O4 (286.1892)


   

3-(3-BOC-AMINO-PYRROLIDIN-1-YL)-2-METHYL-PROPIONICACIDMETHYLESTER

3-(3-BOC-AMINO-PYRROLIDIN-1-YL)-2-METHYL-PROPIONICACIDMETHYLESTER

C14H26N2O4 (286.1892)


   

3-boc-amino-2-piperidineacetic acid ethyl ester

3-boc-amino-2-piperidineacetic acid ethyl ester

C14H26N2O4 (286.1892)


   

Di-tert-butyl piperazine-1,4-dicarboxylate

Di-tert-butyl piperazine-1,4-dicarboxylate

C14H26N2O4 (286.1892)


   

1-Boc-4-[(N-methoxy-N-methylcarbamoyl)methyl]piperidine

1-Boc-4-[(N-methoxy-N-methylcarbamoyl)methyl]piperidine

C14H26N2O4 (286.1892)


   

1,4-Bis(2-phenylethyl)benzene,

1,4-Bis(2-phenylethyl)benzene,

C22H22 (286.1721)


   

[3-(Adamantan-1-yl)-4-methoxyphenyl]boronic acid

[3-(Adamantan-1-yl)-4-methoxyphenyl]boronic acid

C17H23BO3 (286.174)


   

Linogliride

Linogliride

C16H22N4O (286.1794)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE

2,4-DI(TERT-BUTOXY)PYRIMIDIN-5-YLBORONIC ACID HYDRATE

C12H23BN2O5 (286.17)


   

1-Piperazinepropanoicacid, 4-[(1,1-dimethylethoxy)carbonyl]-a-methyl-, methyl ester

1-Piperazinepropanoicacid, 4-[(1,1-dimethylethoxy)carbonyl]-a-methyl-, methyl ester

C14H26N2O4 (286.1892)


   

di-tert-butyl piperazine-1,2-dicarboxylate

di-tert-butyl piperazine-1,2-dicarboxylate

C14H26N2O4 (286.1892)


   

tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate acetate

tert-butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate acetate

C14H26N2O4 (286.1892)


   

spiro-(adamantane-2,9-fluorene)

spiro-(adamantane-2,9-fluorene)

C22H22 (286.1721)


   

N-4-BOC-2-PIPERAZINECARBOXYLICACIDTERT-BUTYLESTER

N-4-BOC-2-PIPERAZINECARBOXYLICACIDTERT-BUTYLESTER

C14H26N2O4 (286.1892)


   

3-(TERT-BUTYL)-1-(3-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE

3-(TERT-BUTYL)-1-(3-METHYLBENZYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE

C16H22N4O (286.1794)


   

Thonzylamine

Thonzylamine

C16H22N4O (286.1794)


D - Dermatologicals > D04 - Antipruritics, incl. antihistamines, anesthetics, etc. > D04A - Antipruritics, incl. antihistamines, anesthetics, etc. > D04AA - Antihistamines for topical use R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Thonzylamine is an orally active H1 histamine receptor antagonist, exhibits good antihistaminic and antianaphylactic properties. Thonzylamine can be used for the research of hypersensitivity diseases, nasal congestion, allergic conjunctivitis and other allergic diseases[1][2].

   

(4R)-4-[(1R)-2,4-dihydroxy-1,4-dimethylcyclohexyl]-4-methyl-1-oxaspiro[2.4]heptane-6,7-diol

(4R)-4-[(1R)-2,4-dihydroxy-1,4-dimethylcyclohexyl]-4-methyl-1-oxaspiro[2.4]heptane-6,7-diol

C15H26O5 (286.178)


   

Peribysin J

Peribysin J

C15H26O5 (286.178)


   

2-[(E)-dec-4-enyl]-3-hydroxypentanedioic acid

2-[(E)-dec-4-enyl]-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   

2-Dec-9-enyl-3-hydroxypentanedioic acid

2-Dec-9-enyl-3-hydroxypentanedioic acid

C15H26O5 (286.178)


   
   
   

4,9-dihydroxy-10-(4-hydroxypentyl)-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

4,9-dihydroxy-10-(4-hydroxypentyl)-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

C15H26O5 (286.178)


   

(1s,2r,5r,6s,7r,8r)-6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

(1s,2r,5r,6s,7r,8r)-6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

C15H26O5 (286.178)


   

(2s,2'r,3s,4r,5's)-3-hydroxy-5'-[(1r)-1-hydroxyhexyl]-4-methyl-[2,2'-bioxolan]-5-one

(2s,2'r,3s,4r,5's)-3-hydroxy-5'-[(1r)-1-hydroxyhexyl]-4-methyl-[2,2'-bioxolan]-5-one

C15H26O5 (286.178)


   

1-[(2r,3r,3ar,6s,7r,7as)-2,6,7-trihydroxy-3,6-dimethyl-hexahydro-1-benzofuran-2-yl]-3-methylbutan-1-one

1-[(2r,3r,3ar,6s,7r,7as)-2,6,7-trihydroxy-3,6-dimethyl-hexahydro-1-benzofuran-2-yl]-3-methylbutan-1-one

C15H26O5 (286.178)


   

(9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

(9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

[C18H24NO2]+ (286.1807)


   

(1s,2r,3s,4ar,6r,8s,8ar)-2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

(1s,2r,3s,4ar,6r,8s,8ar)-2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

C15H26O5 (286.178)


   

6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

6,7-dihydroxy-5-methyl-2-pentyl-3,11-dioxabicyclo[6.2.1]undecan-4-one

C15H26O5 (286.178)


   

(3s,9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

(3s,9bs,11s)-8-hydroxy-11-methoxy-3-methyl-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinolin-3-ium

[C18H24NO2]+ (286.1807)


   

(1s,2r,5s,6s,7r,8r,9s)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

(1s,2r,5s,6s,7r,8r,9s)-6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

C15H26O5 (286.178)


   

(3r,4r,5e,9s,10r)-4,9-dihydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

(3r,4r,5e,9s,10r)-4,9-dihydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-3,4,7,8,9,10-hexahydrooxecin-2-one

C15H26O5 (286.178)


   

3-hydroxy-5'-(1-hydroxyhexyl)-4-methyl-[2,2'-bioxolan]-5-one

3-hydroxy-5'-(1-hydroxyhexyl)-4-methyl-[2,2'-bioxolan]-5-one

C15H26O5 (286.178)


   

(2z)-2-(8-hydroxydecyl)pent-2-enedioic acid

(2z)-2-(8-hydroxydecyl)pent-2-enedioic acid

C15H26O5 (286.178)


   

2-(8-hydroxydecyl)pent-2-enedioic acid

2-(8-hydroxydecyl)pent-2-enedioic acid

C15H26O5 (286.178)


   

2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

2-(3-hydroxyprop-1-en-2-yl)-8,8a-dimethyl-octahydronaphthalene-1,2,3,6-tetrol

C15H26O5 (286.178)


   

6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

6-(hydroxymethyl)-2,10,10-trimethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecane-5,7,8-triol

C15H26O5 (286.178)